Table S3 from PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype

Abstract
HER2-enriched molecular subtype: patients' characteristics according to PIK3CA gene status.